APPOINTMENTS: Recordati, Agios, Celldex, Arena, Probiodrug, REGENXBIO and BioLineRx
Executive Summary
Recordati has appointed a CEO and chair to its board following the death of its CEO and chair and REGENXBIO Inc. has named a new member to its board of directors and. In addition, Probiodrug AG has announced the departure of a board member and chief business officer with BioLineRx Ltd., Celldex Therapeutics Inc., and Arena Pharmaceuticals Inc. all making senior appointments.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.